1. From oncolytic peptides to oncolytic polymers: A new paradigm for oncotherapy
   Hanmeng Liu et al, 2024, Bioactive Materials CrossRef
2. Hosts and Heterologous Expression Strategies of Recombinant Toxins for Therapeutic Purposes
   Luana di Leandro et al, 2023, Toxins CrossRef
3. Expression of Melittin in Fusion with GST in Escherichia coli and Its Purification as a Pure Peptide with Good Bacteriostatic Efficacy
   Lixian Zhou et al, 2020, ACS Omega CrossRef
4. Hosts for Hostile Protein Production: The Challenge of Recombinant Immunotoxin Expression
   Stefania Zuppone et al, 2019, Biomedicines CrossRef
5. A novel tumor-activated ALA fusion protein for specific inhibition on the growth and invasion of breast cancer cells MDA-MB-231
   Xiufeng Liu et al, 2017, Drug Delivery CrossRef
6. Anti-PD-1 Immunotherapy and Bee Venom for Relapsed and Refractory Liposarcoma: A Case Report
   Wei Yang et al, 2021, Frontiers in Oncology CrossRef
7. Biotransformation of β‐hydroxypyruvate and glycolaldehyde to l‐erythrulose by Pichia pastoris strain GS115 overexpressing native transketolase
   Yu‐Chia Wei et al, 2018, Biotechnology Progress CrossRef
8. An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers
   Pratibha Pandey et al, 2023, Nutrients CrossRef
9. Application of bee venom and its main constituent melittin for cancer treatment
   Cui-cui Liu et al, 2016, Cancer Chemotherapy and Pharmacology CrossRef
10. Anticancer Activity of Toxins from Bee and Snake Venom—An Overview on Ovarian Cancer
    Marius Moga et al, 2018, Molecules CrossRef
11. Use of Selected Carbon Nanoparticles as Melittin Carriers for MCF-7 and MDA-MB-231 Human Breast Cancer Cells
    Karolina Daniluk et al, 2019, Materials CrossRef
12. Recent developments in animal venom peptide nanotherapeutics with improved selectivity for cancer cells
    Julien Giribaldi et al, 2021, Biotechnology Advances CrossRef
13. Pharmaceutical Prospects of Bee Products: Special Focus on Anticancer, Antibacterial, Antiviral, and Antiparasitic Properties
    Firzan Nainu et al, 2021, Antibiotics CrossRef
14. In vitro and in vivo anti-tumor effect of Trichobakin fused with urokinase-type plasminogen activator ATF-TBK
    Dan Duc Pham et al, 2024, Molecular Biology Reports CrossRef
15. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy
    Islam Rady et al, 2017, Cancer Letters CrossRef
16. Hive Products: Composition, Pharmacological Properties, and Therapeutic Applications
    Roberto Bava et al, 2024, Pharmaceuticals CrossRef